SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Franklin Electric completed the acquisition of Cat Pumps Corporation on September 4, 2026, for $350 million in cash plus up to $50 million in performance-based restricted stock units. The acquisition expands Franklin Electric's commercial and industrial flow control platform, with Cat Pumps generating approximately $115 million in revenue and $45 million in Adjusted EBITDA, and is expected to be accretive to EPS in 2027.
View raw filing on EDGAR →The filing discloses completion of a previously announced acquisition of 138 branches from BMO Bank N.A., effective September 4, 2026. The transaction involved assumption of approximately $5 billion in deposits and $650 million in loans, representing a material expansion of First Citizens Bank's footprint across multiple regions. This is a completed material acquisition requiring 8-K disclosure under Item 1.01 or 2.01, disclosed here under Item 8.01 as "Other Events."
View raw filing on EDGAR →The RBI has approved Life Insurance Corporation of India's acquisition of up to 9.99% of ICICI Bank's paid-up share capital or voting rights within one year. This represents a material change in ownership structure and control dynamics, meeting the threshold for M&A activity disclosure. The approval is conditional and time-bound, making it a significant corporate development for a reasonable investor assessing the bank's shareholder composition and governance.
View raw filing on EDGAR →The filing discloses a merger transaction between Payoneer Global Inc. and Nuvei Parent (via Merger Sub), with a special stockholder meeting scheduled for September 14, 2026. The 8-K Item 8.01 discusses the merger agreement dated June 12, 2026, supplemental proxy disclosures, and related litigation. This is a material acquisition/change of control event requiring disclosure under Items 1.01 or 2.01, disclosed here via Item 8.01 with supplemental information addressing stockholder litigation and disclosure concerns.
View raw filing on EDGAR →GE Aerospace announced a signed agreement to acquire Consolidated Precision Products (CPP) for $11.75 billion in cash and debt, expected to close in the second half of 2027. The transaction is strategically significant, expected to be accretive to adjusted EPS and free cash flow in year one, and reflects GE's capital allocation priorities in aerospace.
View raw filing on EDGAR →This press release announces receipt of Mexican antitrust clearance for Elemental Royalty's acquisition of Vizsla Royalties Corp., described as the "final regulatory milestone" before closing. The transaction grants Elemental exposure to 2.0%-3.5% net smelter returns royalties on a cornerstone silver-gold asset (Panuco project), representing a material acquisition that will be completed shortly. This is a discrete M&A event requiring disclosure under Item 1.01 or 2.01 equivalent.
View raw filing on EDGAR →The filing discloses a material bank merger between Comenity Bank and Comenity Capital Bank, with regulatory approvals received on July 31, 2026 and expected consummation around October 1, 2026. While the Company states the merger is not expected to have significant financial impact, the transaction itself constitutes a material acquisition/merger activity requiring Item 1.01 disclosure and covenant amendment to the $700 million credit facility, making it a reportable M&A event.
View raw filing on EDGAR →Zhihu Inc.'s wholly-owned subsidiary entered into a Subscription Agreement on September 4, 2026, to invest RMB 1.5 billion in a limited partnership interest in an AI-focused investment fund (Tianjin Lisi Xingshen Equity Investment Partnership). The transaction constitutes a major transaction under Hong Kong Listing Rules with percentage ratios exceeding 25% but less than 100%, requiring shareholder approval at an extraordinary general meeting.
View raw filing on EDGAR →Rigetti's subsidiary entered into an Other Transaction Agreement with the U.S. Department of Commerce on September 4, 2026, securing up to $100 million in government funding for quantum computing R&D. The agreement includes a minority, non-controlling equity stake to the Department (7.7 million shares at $12.92/share), domestic production requirements, IP restrictions, government license rights, and termination provisions, creating material financial obligations and affecting the company's capital structure.
View raw filing on EDGAR →The Company entered into a stock purchase agreement to acquire 8,693,290 shares of common stock for approximately $31.98 million (8,693,290 × $3.68), representing a material capital deployment and potential change in share structure. While this is a share repurchase rather than a traditional M&A transaction, Item 1.01 disclosure of a "material definitive agreement" combined with the substantial dollar amount and audit committee approval under the related-person transaction policy indicates materiality. The transaction involves a related party (Glenn Sanford's family trust) and was structured to require audit committee oversight, signaling its significance to the registrant.
View raw filing on EDGAR →On September 1, 2026, the Company completed a material disposition of the Brookfield Center retail property in Greenville, South Carolina for $10,100,000, with concurrent retirement of $4.3 million in mortgage debt. The Company also entered into a material joint venture agreement (Mira Sav Partners LLC) committing $4.0 million for a 42% preferred equity interest and a $13.5 million construction loan guarantee, and reinstated a property purchase agreement with NPH Ventures at a reduced price of $5.40 million.
View raw filing on EDGAR →Sangamo Therapeutics completed a material asset sale to Eli Lilly and Company on September 4, 2026, pursuant to a court-approved Asset Purchase Agreement dated June 22, 2026. The transaction involved the sale of substantially all of the Company's core technology platforms (AAV capsid engineering, zinc finger protein technology, Modular Integrase genome editing, prion disease program, and related IP) for $50 million in cash plus assumption of specified liabilities.
View raw filing on EDGAR →IPG Photonics entered into a Share Purchase Agreement on September 8, 2026, to acquire 100% of Lumibird Medical from Lumibird S.A. for €300 million in cash plus up to €50 million in contingent earn-out consideration. This is a material acquisition of a wholly-owned subsidiary, disclosed under Item 1.01 (Entry in a Material Definitive Agreement), with closing expected in Q4 2026. The transaction size and strategic nature make it material to investors.
View raw filing on EDGAR →WaFd, Inc. entered into a definitive Agreement and Plan of Merger with EverBank Financial Corp on September 6, 2026, whereby EverBank will merge into WaFd with WaFd as the surviving corporation. The transaction is valued at approximately $3.9 billion with EverBank shareholders receiving approximately 59.2% ownership of the pro forma combined company, subject to regulatory and shareholder approval with expected closing in early 2027.
View raw filing on EDGAR →Neighborhood Intelligence, Inc. terminated the Agreement and Plan of Merger dated July 23, 2026, with F9 Investments, LLC for the acquisition of F9 Brands, Inc. The termination of this previously announced material acquisition affects the company's capital allocation and growth strategy.
View raw filing on EDGAR →Vista announced the completion of a material acquisition consummated on May 7, 2026, acquiring 25.1% working interest in Bandurria Sur and 35.0% working interest in Bajo del Toro blocks in Argentina, adding 66.8 MMboe of proved reserves to the company's portfolio. The transaction involved acquisition of 100% of BSP (holder of 30% Bandurria Sur interest) from Equinor and a 50% Bajo del Toro interest, with back-to-back sales to YPF, representing a significant expansion of Vista's reserve base (from 588.1 to 654.9 MMboe pro forma).
View raw filing on EDGAR →Eagle Financial Services Inc. entered into a definitive merger agreement with John Marshall Bancorp, Inc. on September 7, 2026, whereby EFSI shareholders will receive 2.00 shares of JMSB common stock per EFSI share, creating a combined entity with approximately $4.4 billion in pro forma assets and positioning the combined company as the 5th largest bank headquartered in Virginia.
View raw filing on EDGAR →Solaris Energy Infrastructure completed the acquisition of Omega Foundation Services on September 1, 2026, for approximately $101 million in net cash consideration, $28 million in debt and lease assumption, and issuance of 3.6 million Class A shares. The acquisition expands the company's EPC capabilities and is expected to be immediately accretive to earnings and free cash flow per share.
View raw filing on EDGAR →AEVEX completed the acquisition of Maritime Applied Physics, LLC (BlackSea Technologies) on September 8, 2026, for $600 million enterprise value comprising 12.7 million shares of Class A common stock ($350 million) plus cash and up to $50 million in contingent consideration. The transaction combines two scaled defense providers to create a multi-domain autonomous systems company.
View raw filing on EDGAR →Worthington Steel's subsidiary entered into a Domination and Profit and Loss Transfer Agreement (DPLTA) with Kloeckner & Co SE following completion of a voluntary public takeover offer on June 3, 2026 and Kloeckner's delisting from the Frankfurt Stock Exchange on August 12, 2026. The DPLTA grants Worthington Steel GmbH binding control over Kloeckner's management and profits/losses, with effectiveness expected on January 1, 2027, subject to Kloeckner shareholder approval at an October 23, 2026 meeting.
View raw filing on EDGAR →This Item 8.01 disclosure reports material progress on a previously announced merger: Repligen's acquisition of BioLife Solutions for $11.25 cash and 0.1442 shares per share. The filing confirms that the HSR antitrust waiting period expired on September 3, 2026, removing a key closing condition, and notes that BioLife stockholder approval is scheduled for October 5, 2026. This is a material acquisition activity update that would significantly affect investor assessment of Repligen's strategic direction and capital deployment.
View raw filing on EDGAR →Chime Financial entered into a definitive Merger Agreement on September 8, 2026, to acquire Stride Bank (via Central Service Corporation) for $590 million in cash. The transaction, expected to close in H1 2027, is subject to regulatory approvals from the Federal Reserve and OCC, and will transform Chime from a fintech partner into a bank holding company with direct ownership of banking infrastructure and expected synergies exceeding $100 million.
View raw filing on EDGAR →The filing discloses entry into material definitive agreements—specifically non-redemption agreements between Andretti Acquisition Corp. II, its sponsor, and third-party investors. These agreements are directly tied to the company's business combination timeline and capital structure, extending the deadline from September 9, 2026 to September 9, 2027 and securing commitments to retain approximately 6.5 million shares in the trust account. While technically a financing/capital arrangement rather than a traditional M&A transaction, the agreements are material to the company's ability to consummate its pending business combination and are disclosed under Item 1.01 (Entry into a Material Definitive Agreement), making them a core component of the M&A process for a SPAC.
View raw filing on EDGAR →Elmet Group entered into a definitive Asset Purchase Agreement on September 3, 2026, to acquire substantially all assets and operations of OSRAM GmbH's metal production facility in Schwabmünchen, Germany, including tungsten and molybdenum manufacturing operations. This material acquisition establishes Elmet's first European manufacturing footprint, with an expected closing in Q1 2027 and a purchase price involving €18 million negative base plus working capital adjustments and a €2.5 million vendor loan.
View raw filing on EDGAR →NMP Acquisition Corp. entered into a definitive Business Combination Agreement on September 4, 2026, with GTS Holdings, LLC to effect a merger that will result in GTS becoming a publicly traded company, valuing GTS at a $400 million enterprise value in an all-stock transaction.
View raw filing on EDGAR →Meshflow Acquisition Corp. (a SPAC) entered into a definitive Business Combination Agreement with HGP Intelligent Energy, LLC, structured as a merger that will result in HGP becoming a publicly traded company under newly formed Delaware holding company Leyte Parent, Inc. The transaction values HGP at $800 million pre-money equity value with pro forma enterprise value of approximately $921 million and is expected to provide approximately $345 million in gross proceeds.
View raw filing on EDGAR →Healthcare Triangle entered into a Separation and Distribution Agreement and Transition Services Agreement on September 2, 2026, to effect a planned spin-off of its wholly-owned subsidiary Teyame AI Holdings, Inc. The company intends to distribute a minority interest in Teyame's common stock to HCTI shareholders on a pro rata basis, with HCTI retaining majority ownership, and the parties will subsequently operate as separate public companies. This constitutes a material change of control and structural reorganization requiring Form 10 registration and Nasdaq listing approval, making it a material M&A activity under Item 1.01.
View raw filing on EDGAR →The filing discloses two material dispositions: (1) sale of the Iowa Site for $1.5 million under a definitive agreement with Simple Mining, LLC, and (2) sale of approximately 5,500 proprietary mining machines (the Company's entire legacy fleet) for ~$3.1 million under a binding term sheet with RepairBit, LLC. These are material asset dispositions totaling approximately $4.6 million, representing a significant reduction in the Company's operational assets and generating substantial liquidity. The Iowa Agreement is explicitly a "definitive agreement" under Item 1.01, and the Mining Machine Agreement is described as a "binding term sheet," both triggering disclosure obligations for material dispositions.
View raw filing on EDGAR →The 6-K discloses entry into a VIE Control Master Acquisition Agreement on September 8, 2026, whereby Jin Medical International will obtain contractual control over Huaxia Qiying (the Target) through VIE arrangements with Chenglan Kangxu and related parties. The transaction involves aggregate consideration of US$159.4 million and issuance of 71.3 million Class A ordinary shares, plus ancillary asset and equity transfers. This constitutes a material acquisition activity under Item 1.01 of Form 8-K (or its 6-K equivalent), with substantial financial and operational implications for the registrant's expansion into ginseng-related biological assets and senior-health platform development.
View raw filing on EDGAR →SUNation and Suniva entered into a First Amendment to their Merger Agreement dated June 5, 2026, amending material terms of the proposed merger transaction. The amendment modifies key closing conditions, including authorized share increases, stockholder voting requirements, net cash requirements, and related-party loan conversion terms. This constitutes a material amendment to an ongoing M&A transaction that would materially affect investor assessment of the deal structure and likelihood of completion.
View raw filing on EDGAR →The exhibit reports results of bondholders' meetings held on September 4, 2026, where bondholders of Ecopetrol's 2010 and 2013 domestic bond issuances voted to approve a proposed merger by absorption between Ecopetrol S.A. (surviving entity) and Parque Solar Portón del Sol S.A.S. (absorbed entity). The merger received supermajority approval (74.92% and 80.77% of outstanding principal amounts respectively), constituting a material acquisition/change-of-control event requiring disclosure under Item 1.01 or 2.01 of the 8-K taxonomy.
View raw filing on EDGAR →The filing discloses termination of a material merger agreement between Cayson Acquisition Corp and Mango Financial Group Limited that had been in place since July 11, 2025. The termination on September 2, 2026 represents a material change in the Company's M&A status, with ongoing financial obligations (promissory notes with conversion rights) and the SPAC resuming its search for a target business combination. This is a termination of a material definitive agreement under Item 1.02, which is a core M&A event type.
View raw filing on EDGAR →This exhibit discloses the completion of a material acquisition: MKDWELL Tech Inc. acquired 100% of Landvision Inc. for US$240 million in stock consideration (30 million shares at US$8.00 per share), completed on August 7, 2026. The pro forma financial statements show the combined entity with Landvision's revenues of US$132.1 million for the six-month period, representing a transformative transaction that materially changes the registrant's asset base, equity structure, and operating profile. This is a classic M&A completion disclosure under Item 1.01 / 2.01 equivalent for a 6-K.
View raw filing on EDGAR →Silver Bow Mining announced completion of the initial closing in its acquisition of the Jefferson County Metallurgical Complex from Montana Tunnels Mining, Inc., following U.S. Bankruptcy Court approval under Section 363 of the Bankruptcy Code on September 4, 2026. The company funded approximately $28.58 million into escrow to satisfy creditor obligations as part of the transaction. This represents a material acquisition of specified assets, with a final closing contemplated subject to shareholder and NYSE American approval.
View raw filing on EDGAR →John Marshall Bancorp and Eagle Financial Services entered into a definitive Agreement and Plan of Merger on September 7, 2026, whereby EFSI will merge into John Marshall in an all-stock transaction valued at approximately $253 million (2.0 shares of JMSB per EFSI share). The transaction creates a combined $4.4 billion entity with 23 banking offices, expected to close in Q1 2027, and includes executive leadership changes at the effective time.
View raw filing on EDGAR →International Stem Cell Corporation completed the sale of 100% of the membership interests of its wholly-owned subsidiary Lifeline Cell Technology, LLC to American Type Culture Collection, Inc. on September 1, 2026, for an adjusted purchase price of $25,250,000. This is a material disposition of a significant asset (a wholly-owned subsidiary) that would substantially affect the registrant's financial position and operations going forward, as evidenced by the pro forma financial statements showing elimination of LCT's substantial revenues and operations.
View raw filing on EDGAR →Curaleaf issued a fact sheet on September 8, 2026, addressing what it characterizes as misleading statements from Aurora Cannabis regarding Curaleaf's proposal to acquire Aurora. The disclosure centers on Curaleaf's pending acquisition offer—specifically defending the terms (45% premium, US$4.00–US$5.00 per share consideration structure) and responding to Aurora's board rejection and shareholder communications. This is a material M&A activity disclosure, as it relates to an active acquisition proposal and Curaleaf's public defense of deal terms to shareholders.
View raw filing on EDGAR →The filing discloses a proposed all-share acquisition of 80 Mile plc by Greenland Energy Company, announced under Rule 2.4 of the City Code on Takeovers and Mergers. The transaction values 80 Mile at £61.48 million and represents a 42.86% to 64.18% premium to recent trading prices. This is a material M&A activity that would substantially affect the registrant's business and shareholder base, even though it remains subject to pre-conditions and is not yet a firm offer.
View raw filing on EDGAR →Circle Internet Group entered into a definitive Share Purchase Agreement on September 4, 2026, to acquire Tazapay Pte. Ltd., a Singapore-based cross-border payments platform, for approximately $400 million in Circle Common Stock. The acquisition brings $25+ billion in annualized payment volume, 60+ banking and fintech partners, and 100+ payout markets into Circle's ecosystem, with expected closing in 2027.
View raw filing on EDGAR →D-Wave entered into a definitive Other Transaction Agreement with the U.S. Department of Commerce under the CHIPS and Science Act for up to $100 million in funding for quantum computing R&D, coupled with issuance of 7,095,721 shares of common stock to the Department at $14.093 per share, representing a material capital transaction and strategic partnership with significant equity dilution.
View raw filing on EDGAR →ICICI Bank completed a purchase of 29,015,693 equity shares (approximately 2.00% of equity) in its subsidiary ICICI Prudential Life Insurance Company Limited through multiple tranches between July 22 and September 2, 2026, for approximately ₹14.70 billion, increasing its shareholding from approximately 50.8% to 52.8%. This represents a material acquisition activity involving a change in ownership stake in a significant subsidiary.
View raw filing on EDGAR →NVIDIA entered into a definitive agreement to acquire Hugging Face for approximately $11.9 billion plus up to $1.0 billion in equity-based retention, with closing expected in H1 2027. This is a material acquisition transaction disclosed under Item 8.01 (Other Events), representing a significant capital deployment and strategic business combination that would materially affect a reasonable investor's assessment of NVIDIA.
View raw filing on EDGAR →Medicus Pharma entered into a Co-Development and License Agreement with Pfizer on September 2, 2026, granting an exclusive, worldwide license to develop and commercialize CD228V, an early-stage antibody-drug conjugate. The transaction involves a $12.0 million upfront payment, $15.0 million deferred payment, potential milestone payments exceeding $1.0 billion, and royalties on net sales. This constitutes a material strategic transaction involving acquisition of intellectual property rights and a significant financial commitment that would materially affect a reasonable investor's assessment of the company's pipeline and financial obligations.
View raw filing on EDGAR →AbbVie announced the completion of its acquisition of Apogee Therapeutics for approximately $10.9 billion ($135.11 per share in cash). This is a material acquisition disclosed under Item 7.01 (Regulation FD Disclosure) via press release. The filing explicitly states "AbbVie Inc. (the "Company") issued a press release announcing the completion of its acquisition of Apogee Therapeutics, Inc." The transaction materially expands AbbVie's immunology pipeline with late-stage assets (zumilokibart and APG273) and is expected to impact 2026-2027 earnings per share.
View raw filing on EDGAR →GeoPark announces a major strategic acquisition of the Bare Block in Venezuela through a Production Participation Contract (CPP) framework with PDVSA, structured as an exchange of 42.1 million GeoPark shares (at US$12.22/share, a 26% premium) to Grupo Gilinski, resulting in Grupo Gilinski becoming a controlling shareholder with ~56.3% ownership. This constitutes a material acquisition and change of control transaction that fundamentally transforms GeoPark's portfolio and ownership structure, with expected production increases to 75–85 kboepd by 2030 (2.7x current levels) and significant EBITDA accretion.
View raw filing on EDGAR →Net Power Inc. closed the acquisition of EMPower USA's contractual rights and obligations under an EPC agreement for a 123 MW natural gas power generation facility on August 31, 2026. The transaction involved $58.9 million in cash consideration plus assumption of approximately $177.8 million in future payment commitments, representing a material acquisition of contractual rights and project assets that advances the company's Project Permian development strategy. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and constitutes a material acquisition activity.
View raw filing on EDGAR →Apogee Therapeutics completed its merger with AbbVie, becoming an indirect wholly owned subsidiary of AbbVie in a transaction valued at approximately $10.9 billion. The merger resulted in a change of control, conversion of Apogee shares into merger consideration, delisting from Nasdaq, and replacement of all directors and executive officers with AbbVie-designated personnel.
View raw filing on EDGAR →Bank7 Corp. has been designated the successful bidder in a court-supervised auction to acquire approximately 71% of Century Financial Services Corporation for $91 million (net $89 million). This represents a material acquisition of a controlling interest in a bank holding company with $1.36 billion in assets, creating a combined organization with approximately $3.4 billion in assets. The transaction is a significant M&A activity subject to regulatory approvals and expected to close in Q4 2026.
View raw filing on EDGAR →Shell plc announces completion of its acquisition of ARC Resources Ltd., a material M&A transaction. The filing states "Shell plc has completed the previously announced agreement...to acquire ARC Resources Ltd." with an enterprise value of approximately US$16.5 billion, funded via US$3.3 billion in cash and US$10.6 billion in new Shell shares. The transaction adds approximately 370 kboe/d of production and is expected to generate double-digit returns and be accretive to free cash flow from 2027 onwards—clearly material to a reasonable investor's assessment of Shell's strategic direction and financial position.
View raw filing on EDGAR →The Korean Government announced a "Plan for Functional Reform of Public Institutions" proposing to merge five power generation subsidiaries of Korea Electric Power Corporation into a single entity. This constitutes a material change of control or restructuring of the registrant's operating subsidiaries. While the disclosure is preliminary and unconfirmed, the announcement of a government-mandated merger proposal affecting core operating assets qualifies as ma_activity under Items 1.01 or 2.01 (material acquisition or change of control), even though the transaction is not yet finalized.
View raw filing on EDGAR →